Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation

被引:51
|
作者
Blanc, JJ
Voinov, C
Maarek, M
机构
[1] Brest Univ Hosp, Dept Cardiol, Brest, France
[2] Med Dept Labs, Knoll, France
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 84卷 / 09期
关键词
D O I
10.1016/S0002-9149(99)00493-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with recent-onset atrial fibrillation (AF), restoration of sinus rhythm is considered to be the First-line therapeutic option, Although this conversion might be obtained by direct-current shock or intravenous antiar- rhythmic drugs, administration of an oral loading dose of class I or III antiarrhythmic drugs is more simple and convenient. This prospective, randomized, multicenter study compares the time to conversion to sinus rhythm obtained with an oral loading dose of propafenone or amiodarone, Patients with recent-onset AF (<2 weeks), without contraindications for the 2 drugs, were randomly assigned to be treated with propafenone (600 mg for the first 24 hours and if necessary a repeated dose of 300 mg for 24 hours) or amiodarone (30 mg/kg for the first 24 hours and if necessary a repeated dose of 15 mg/kg for 24 hours). Exact conversion time during the first 24 hours was determined by Holter monitoring. In each treatment group 43 patients with the same baseline characteristics were included, The median time for restoration of sinus rhythm was shelter (p = 0.05) in the propafenone (2.4 hours) than in the amiodarone (6.9 hours) group, After 24 hours (56% in the propofenone and 47% in the amiodarone group) and 48 hours, the same proportion of patients in the 2 groups recovered sinus rhythm (no serious adverse events were noticed). Thus, oral loading dose of propafenone or amiodarone was safe with a similar conversion rate of recent-onset AF, Propofenone had a faster action, (C) 1999 by Excerpta Medico, Inc.
引用
收藏
页码:1029 / 1032
页数:4
相关论文
共 50 条
  • [41] Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease - A randomized, controlled trial
    Boriani, G
    Biffi, M
    Capucci, A
    Botto, GL
    Broffoni, T
    Rubino, I
    DellaCasa, S
    Sanguinetti, M
    Magnani, B
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) : 621 - 625
  • [42] Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
    Zhang, Nixiao
    Tse, Gary
    Dahal, Shristi
    Yang, Yajuan
    Gong, Mengqi
    Chan, Calista Zhuo Yi
    Liu, Enzhao
    Xu, Gang
    Letsas, Konstantinos P.
    Korantzopoulos, Panagiotis
    Li, Guangping
    Liu, Tong
    CARDIOLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [43] Oral antiarrhythmic drugs in converting recent onset atrial fibrillation
    Deneer, VHM
    Borgh, MBI
    Kingma, JH
    Lie-A-Huen, L
    Brouwers, JRBJ
    PHARMACY WORLD & SCIENCE, 2004, 26 (02): : 66 - 78
  • [44] Oral antiarrhythmic drugs in converting recent onset atrial fibrillation
    Vera H.M. Deneer
    Marieke B.I. Borgh
    J. Herre Kingma
    Loraine Lie-A-Huen
    Jacobus R.B.J. Brouwers
    Pharmacy World and Science, 2004, 26 : 66 - 78
  • [45] Procainamide-propafenone-amiodarone: which is preferred intravenously for the conversion of recent onset atrial fibrillation?
    Kochiadakis, GE
    Igoumenidis, NE
    Marketou, ME
    Mavrakis, HE
    Kaleboubas, MD
    Zacharis, EA
    Phillipou, OK
    Chrysostomakis, SI
    Vardas, PE
    EUROPEAN HEART JOURNAL, 2000, 21 : 472 - 472
  • [46] Recent-onset atrial fibrillation: Placebo-controlled evaluation of the efficacy of propafenone in elderly subjects
    Boriani, G
    Capucci, A
    Biffi, M
    Botto, G
    Rubino, I
    DellaCasa, S
    Broffoni, T
    Sanguinetti, M
    Magnani, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 51140 - 51140
  • [47] Oral loading with propafenone: A placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation
    Boriani, G
    Biffi, M
    Capucci, A
    Botto, GL
    Broffoni, T
    Rubino, I
    Della Casa, S
    Sanguinetti, M
    Branzi, A
    Magnani, B
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (11): : 2465 - 2469
  • [48] Oral propafenone cost-effectiveness in patients with recent onset atrial fibrillation
    Villani, GQ
    Piepoli, MF
    Marrazzo, N
    Rosi, A
    Capucci, A
    EUROPEAN HEART JOURNAL, 2001, 22 : 327 - 327
  • [49] Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study
    Galve, E
    Rius, T
    Ballester, R
    Artaza, MA
    Arnau, JM
    GarciaDorado, D
    SolerSoler, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) : 1079 - 1082
  • [50] Procainamide, propafenone, amiodarone: A comparative study of their efficacy and safety for the conversion of recent onset atrial fibrillation
    Igoumenidis, NE
    Kochiadakis, GE
    Hamilos, MI
    Marketou, ME
    Klapsinos, NC
    Skalidis, EI
    Vardas, PE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 10A - 10A